Skip to main content
Premium Trial:

Request an Annual Quote

Applied Biosystems: Sep 18, 2008

Premium
Applied Biosystems has recently introduced the TaqMan global service provider program for RNA expression analysis.
 
The program was “created for research scientists who do not have laboratories equipped for performing TaqMan assays, or who choose to outsource their experiments to obtain … data, generated by authorized third parties using Applied Biosystems' TaqMan RNA expression analysis reagents,” the company said. “This program will provide these scientists with a comprehensive solution for completing a variety of biological sample processing and data analysis projects that incorporate gold-standard TaqMan assay chemistry.”

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.